Century Therapeutics, Inc.·4

Mar 16, 4:03 PM ET

Russotti Gregory 4

Research Summary

AI-generated summary

Updated

Century Therapeutics (IPSC) CTO Gregory Russotti Sells 10,076 Shares

What Happened

  • Gregory Russotti, Chief Technology and Manufacturing Officer of Century Therapeutics (IPSC), sold 10,076 shares on March 12, 2026. The shares were disposed at $2.55 each, netting $25,684.
  • The filing notes these sales were automatic to satisfy tax withholding obligations on vested restricted stock units (RSUs) and were not at the Reporting Person's discretion — a routine, administrative sale rather than an expressed market view.

Key Details

  • Transaction date: 2026-03-12; sale price: $2.55 per share; total proceeds: $25,684.
  • Transaction type: Sale (shares sold to cover tax withholding on RSU vesting).
  • Footnote: Sales were automatic to cover tax withholding (not discretionary).
  • Filing date: 2026-03-16. (The transaction occurred March 12; Form 4s are typically due within two business days — review the filing page for any late-filing flag.)
  • Shares owned after the transaction: not specified in the excerpt provided.

Context

  • Sales to cover tax withholding on RSU vesting are common and generally administrative; they do not necessarily indicate the insider's sentiment about the company's prospects.
  • This was not an options exercise or a voluntary open-market sale; it was a cashless/automatic disposition solely for tax withholding purposes.